The Discounted Cash Flow (DCF) valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 6.04 CAD. With the latest stock price at 2.71 CAD, the upside of Medexus Pharmaceuticals Inc based on DCF is 122.9%.
Based on the latest price of 2.71 CAD and our DCF valuation, Medexus Pharmaceuticals Inc (MDP.TO) is a buy. buying MDP.TO stocks now will result in a potential gain of 122.9%.
| Range | Selected | |
| WACC / Discount Rate | 8.1% - 10.6% | 9.4% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 4.39 - 9.71 | 6.04 |
| Upside | 62.2% - 258.4% | 122.9% |